title: [Inflammation and remodeling of the distal airways: studies in humans and experimental models].
abstract: Asthma is characterized by inflammation and remodeling of the airways, giving rise to airway obstruction and symptoms of wheezing, chest tightness, cough and dyspnea. Most of these observations arise from the study of samples obtained from the central airways by distinct methods. However, it is currently accepted that this inflammatory process occurs not only in the central airway but also in the small airway and even in the pulmonary parenchyma of all asthmatic patients, even those with mild asthma. CD4+ lymphocytes, activated eosinophils and IL-5 mRNA expression are present in a greater quantity in the small airways. Also present is remodeling, with an increase in submucosal thickness, the muscular layer and adventitia. This inflammatory process causes a disconnection between the pulmonary parenchyma and the airway, giving rise to obstruction of the small airway, which is currently considered to be predominant in asthmatic patients. Likewise, studies of experimental asthma in animals support the substantial role of the distal airway. Recognition that asthma affects the entire airway could be clinically important and lead to the distal lung being considered as a target in any effective therapeutic strategy. However, longitudinal studies are required to evaluate the impact of distal airway inflammation and its treatment in asthma.
authors.affiliation: Servicio de Neumología, Hospital de la Santa Creu i Sant Pau, Barcelona, España. DRamosB@santpau.cat
authors.forename: David
authors.initials: D
authors.lastname: Ramos-Barbón
authors.forename: Antonio
authors.initials: A
authors.lastname: Parra-Arrondo
mesh_terms: D000402:Airway Obstruction / Q000209:etiology; D056151:Airway Remodeling / Q000502:physiology; D000818:Animals; D018927:Anti-Asthmatic Agents / Q000494:pharmacology / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D001980:Bronchi / Q000473:pathology*; D016535:Bronchial Hyperreactivity / Q000209:etiology; D055745:Bronchioles / Q000473:pathology; D003948:Diagnostic Techniques, Respiratory System; D004195:Disease Models, Animal; D016326:Extracellular Matrix Proteins / Q000378:metabolism; D006801:Humans; D007249:Inflammation; D020782:Matrix Metalloproteinases / Q000378:metabolism; D011650:Pulmonary Alveoli / Q000473:pathology; D011657:Pulmonary Eosinophilia / Q000209:etiology; D013045:Species Specificity
chemical_list: D018927:Anti-Asthmatic Agents; D016326:Extracellular Matrix Proteins; D020782:Matrix Metalloproteinases